Steve Harr - Net Worth and Insider Trading
Steve Harr Net Worth
The estimated net worth of Steve Harr is at least $66 Million dollars as of 2024-11-13. Steve Harr is the CFO & Head, Corp. Development of Juno Therapeutics Inc and owns about 763,332 shares of Juno Therapeutics Inc (JUNO) stock worth over $66 Million. Details can be seen in Steve Harr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steve Harr has not made any transactions after 2017-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steve Harr
Steve Harr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steve Harr owns 1 companies in total, including Sana Biotechnology Inc (SANA) .
Click here to see the complete history of Steve Harr’s form 4 insider trades.
Insider Ownership Summary of Steve Harr
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SANA | Sana Biotechnology Inc | 2021-02-03 | director & President & CEO |
Steve Harr Latest Holdings Summary
Steve Harr currently owns a total of 1 stock. Steve Harr owns 763,332 shares of Juno Therapeutics Inc (JUNO) as of December 21, 2017, with a value of $66 Million.
Latest Holdings of Steve Harr
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JUNO | Juno Therapeutics Inc | 2017-12-21 | 763,332 | 86.96 | 66,379,351 |
Holding Weightings of Steve Harr
Steve Harr Form 4 Trading Tracker
According to the SEC Form 4 filings, Steve Harr has made a total of 0 transactions in Juno Therapeutics Inc (JUNO) over the past 5 years. The most-recent trade in Juno Therapeutics Inc is the sale of 8,750 shares on December 21, 2017, which brought Steve Harr around $391,650.
Insider Trading History of Steve Harr
- 1
Steve Harr Trading Performance
Steve Harr Ownership Network
Ownership Network List of Steve Harr
Ownership Network Relation of Steve Harr
Steve Harr Owned Company Details
What does Sana Biotechnology Inc do?
Who are the key executives at Sana Biotechnology Inc?
Steve Harr is the director & President & CEO of Sana Biotechnology Inc. Other key executives at Sana Biotechnology Inc include director & Head of SanaX Richard Mulligan , 10 percent owner Keith Crandell , and 10 percent owner Arch Venture Fund X Overage, L.p. .
Sana Biotechnology Inc (SANA) Insider Trades Summary
Over the past 18 months, Steve Harr made no insider transaction in Sana Biotechnology Inc (SANA). Other recent insider transactions involving Sana Biotechnology Inc (SANA) include a net sale of 949,000 shares made by Flagship Ventures Fund V, L.p. , a net purchase of 1,818,181 shares made by Arch Venture Fund X Overage, L.p. , and a net purchase of 1,818,181 shares made by Keith Crandell .
In summary, during the past 3 months, insiders sold 300,000 shares of Sana Biotechnology Inc (SANA) in total and bought 0 shares, with a net sale of 300,000 shares. During the past 18 months, 1,349,000 shares of Sana Biotechnology Inc (SANA) were sold and 5,454,543 shares were bought by its insiders, resulting in a net purchase of 4,105,543 shares.
Sana Biotechnology Inc (SANA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sana Biotechnology Inc Insider Transactions
Steve Harr Mailing Address
Above is the net worth, insider trading, and ownership report for Steve Harr. You might contact Steve Harr via mailing address: 307 Westlake Ave. North, Ste. 300, Seattle Wa 98109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
